Source
- Journal of Endocrinological Investigation .
Takeaway
- Type 2 diabetes (T2D) affects about one-quarter of patients with primary aldosteronism (PA).
- Risk factors for T2D development in those with PA are the same as those in the general population.
- Medical and surgical treatment provide similar glycaemic benefits in people with PA...